# Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer

> **NCT04892303** · PHASE1 · RECRUITING · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 48 (estimated)

## Conditions studied

- Recurrent Thyroid Cancer

## Interventions

- **COMBINATION_PRODUCT:** Combination treatment (CXRPT) of external beam radiation (XRT) plus radioactive iodine (RAI)

## Key facts

- **NCT ID:** NCT04892303
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-17
- **Primary completion:** 2027-12
- **Final completion:** 2030-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04892303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04892303, "Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04892303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*